![Gary Sender](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Sender
Director/Board Member at
SCHRÖDINGER, INC.
Net worth: 188 463 $ as of 31/05/2026
Profile
Gary L.
Sender currently serves as Independent Director at Schrödinger, Inc. since 2019, Independent Director at iBio, Inc. since 2020, Director at Elucida Oncology, Inc. since 2021, Independent Director at Harmony Biosciences Holdings, Inc. since 2020, Director at Harmony Biosciences LLC, Director at Gennao Bio, Inc. since 2021, Director at Apnimed, Inc., and President at Sender Consulting LLC.
Former roles include Senior Vice President-Finance at Shire Plc from 2009 to 2015, CFO and Vice President-Finance & Administration at Tengion, Inc. from 2004 to 2009, Chief Financial Officer at Nabriva Therapeutics GmbH from 2016 to 2017, Chief Financial Officer & Executive Vice President at Synergy Pharmaceuticals LLC from 2015 to 2016, Chief Financial Officer at Nabriva Therapeutics Plc from 2016 to 2021, and Head-Investor Relations & Treasury at Merck & Co. Education includes an MBA from Carnegie Mellon University and undergraduate studies at Boston University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCHRODINGER, INC. 0.02% | 01/04/2026 | 11,250 ( 0.02% ) | 171 000 $ | 31/05/2026 |
IBIO, INC. 0.03% | 20/11/2025 | 9,191 ( 0.03% ) | 17 463 $ | 31/05/2026 |
| 14/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Gary Sender active positions
| Companies | Position | Start |
|---|---|---|
| SCHRÖDINGER, INC. | Director/Board Member | 01/07/2019 |
| IBIO, INC. | Director/Board Member | 14/10/2020 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director/Board Member | 01/08/2020 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Director/Board Member | 29/04/2021 |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Director/Board Member | - |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Director/Board Member | 08/09/2021 |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Director/Board Member | - |
Former positions of Gary Sender
| Companies | Position | End |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Director of Finance/CFO | 12/03/2021 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Director of Finance/CFO | 23/06/2017 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Gary Sender
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
Apnimed, Inc.
Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Health Technology |
Merck & Co.
 Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Finance |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Health Technology |
- Stock Market
- Insiders
- Gary Sender
